secwatch.observer — SEC 8-K summary
======================================

Issuer:     Transcode Therapeutics, Inc. (RNAZ)
CIK:        0001829635
Form:       8-K
Filed at:   2024-07-24T23:59:59+00:00
Accession:  0001104659-24-082155
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TransCode Therapeutics prices $3.0M public offering of 10M shares at $0.30
--------------------------------------------------------------------------

- Offering of 10,000,000 common shares at $0.30 per share for gross proceeds of $3.0M.
- Placement agent warrants to purchase 500,000 shares at $0.375, expiring July 22, 2029.
- Expected close on July 24, 2024; proceeds for TTX-MC138 clinical trials and working capital.
- ThinkEquity acting as sole placement agent; securities offered via effective S-3 shelf.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829635/000110465924082155/0001104659-24-082155-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829635/000110465924082155/tm2416389d3_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-082155

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer